Overview
Pyruvate metabolism disorder (Orphanet code 254746) is a group classification encompassing a range of rare inherited metabolic conditions in which the body's ability to properly metabolize pyruvate is impaired. Pyruvate is a critical molecule at the crossroads of several metabolic pathways, including glycolysis, gluconeogenesis, and the citric acid (Krebs) cycle. Disorders of pyruvate metabolism include pyruvate dehydrogenase complex deficiency, pyruvate carboxylase deficiency, and phosphoenolpyruvate carboxykinase deficiency, among others. These conditions primarily affect the nervous system and energy-dependent organs such as the brain, muscles, heart, and liver, because impaired pyruvate metabolism leads to deficient cellular energy production and often to lactic acidosis. Key clinical features vary depending on the specific enzyme affected but commonly include lactic acidosis, developmental delay, intellectual disability, seizures, hypotonia (low muscle tone), failure to thrive, and progressive neurological deterioration. Some patients may present with structural brain abnormalities, movement disorders, or episodes of metabolic crisis triggered by illness or fasting. Onset is typically in the neonatal or infantile period, though milder forms may present later in childhood. Treatment is largely supportive and depends on the specific underlying enzyme deficiency. Dietary interventions such as a ketogenic diet have shown benefit in some forms, particularly pyruvate dehydrogenase complex deficiency, by providing an alternative energy source (ketone bodies) that bypasses the metabolic block. Thiamine supplementation may be helpful in thiamine-responsive cases. Cofactor supplementation, avoidance of fasting, and management of acute metabolic crises with bicarbonate and glucose are also part of the therapeutic approach. Despite treatment, prognosis remains guarded for many patients, particularly those with severe neonatal presentations.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
5 eventsNational Heart Centre Singapore — PHASE2
University of Maryland, Baltimore — PHASE1
University of Maryland, Baltimore — PHASE2
University of Texas Southwestern Medical Center — EARLY_PHASE1
Sunnybrook Health Sciences Centre — PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Pyruvate metabolism disorder.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pyruvate metabolism disorder at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pyruvate metabolism disorder.
Community
No community posts yet. Be the first to share your experience with Pyruvate metabolism disorder.
Start the conversation →Latest news about Pyruvate metabolism disorder
Disease timeline:
New recruiting trial: Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
A new clinical trial is recruiting patients for Pyruvate metabolism disorder
New recruiting trial: Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection
A new clinical trial is recruiting patients for Pyruvate metabolism disorder
New recruiting trial: Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body
A new clinical trial is recruiting patients for Pyruvate metabolism disorder
New recruiting trial: Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
A new clinical trial is recruiting patients for Pyruvate metabolism disorder
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pyruvate metabolism disorder
What is Pyruvate metabolism disorder?
Pyruvate metabolism disorder (Orphanet code 254746) is a group classification encompassing a range of rare inherited metabolic conditions in which the body's ability to properly metabolize pyruvate is impaired. Pyruvate is a critical molecule at the crossroads of several metabolic pathways, including glycolysis, gluconeogenesis, and the citric acid (Krebs) cycle. Disorders of pyruvate metabolism include pyruvate dehydrogenase complex deficiency, pyruvate carboxylase deficiency, and phosphoenolpyruvate carboxykinase deficiency, among others. These conditions primarily affect the nervous system
Which specialists treat Pyruvate metabolism disorder?
21 specialists and care centers treating Pyruvate metabolism disorder are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.